SCHEMBL7244016

SCHEMBL7244016

CN(C)CCN(C)C(=O)c1ccc2c(c1)nc(CCc1ccc(C#N)cc1)n2C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 1/20 0.49
▸ CNR2 P34972 8/20 0.45
▸ CNR1 P21554 4/20 0.43
▸ NSD2 O96028 1/20 0.40
▸ NR3C2 P08235 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ HDAC1 Q13547 3/20 0.39
▸ HDAC8 Q9BY41 2/20 0.39
▸ EGLN1 Q9GZT9 1/20 0.39
▸ HDAC6 Q9UBN7 3/20 0.39
▸ ITK Q08881 2/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC10 Q969S8 1/20 0.39
▸ HDAC5 Q9UQL6 1/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ JAK1 P23458 1/20 0.39
▸ TYK2 P29597 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7244700 0.91 F2 (0.48) F2CNR2CNR1NSD2HDAC1
SCHEMBL7247840 0.90 NSD2 (0.52) F2CNR2CNR1NSD2HDAC1
SCHEMBL7249869 0.86 F2 (0.49) F2CNR2CNR1NSD2HDAC1
SCHEMBL7245089 0.86 F2 (0.52) F2CNR2CNR1HDAC1HDAC8
Hydrochloric Acid SCHEMBL7250157 0.85 F2 (0.65) F2CNR2
SCHEMBL6486632 0.84 F2 (0.50) F2HDAC1HDAC8HDAC6ITK
SCHEMBL7246372 0.83 PDK1 (0.51) F2NSD2HDAC1HDAC8HDAC6
SCHEMBL7244672 0.83 F2 (0.47) F2HDAC1HDAC8HDAC6ITK
Hydrochloric Acid SCHEMBL7244675 0.83 F2 (0.49) F2HDAC1HDAC8HDAC6ITK
SCHEMBL7246953 0.81 F2 (0.46) F2CNR2CNR1HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6512000-B1 Aminocarbonyl- substituted benzimidazole derivatives for the treatment of diseases in which inhibition of tryptase is of therapeutic such as for treating an inflammatory or allergic disease BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-01-28 — — US disclosed
Send feedback